List of abbreviations {#nomen0010}
=====================

ACE

:   angiotensin-converting enzyme

CoV

:   Coronaviridae

COVID-19

:   Coronavirus disease 2019

CCB

:   calcium channel blocker

DM

:   Diabetes mellitus

FDA

:   Food and drug administration

HIV

:   Human immunodeficiency virus

LDL

:   Low-density lipoprotein

MERS

:   Middle East Respiratory syndrome

PCSK

:   pro-protein convertase subtilizing/kexin

SARS

:   Severe acute respiratory distress syndrome

The Coronaviridae family of viruses incorporates an assortment of pathogens that are linked to a zoonotic origin. This is one of the fundamental elements causing former outbreaks of the severe acute respiratory syndrome (SARS- CoV) and Middle East respiratory syndrome (MERS-CoV) ([@bib35]), as well as the current pandemic severe acute respiratory syndrome coronavirus ([@bib32]) (SARS-CoV-2) or Coronavirus Disease 2019 (COVID-19).

However, COVID-19 has shown exponential dissemination in the community, faster than MERS and SARS ([@bib34]). This is supported by confirmed metrics on the total number of COVID-19 cases (as of June 2nd 2020) to be 6.06 million ([@bib42]), compared to SARS-CoV-1 and MERS that were 8439 and 2519 ([@bib6]) respectively. Furthermore, the clinical picture of COVID-19, which is due to multi-organ system damage on account of microvascular injury, seems to be slightly different than that of SARS-CoV-1 and MERS, mainly targeting the lungs ([@bib2], [@bib3]; [@bib4], [@bib5]).

1. Furin and COVID-19 infection {#sec1}
-------------------------------

FURIN is an enzyme that belongs to the PCSK (pro-protein convertase subtilizing/kexin) family, a type 1 membrane-bound protease that processes latent precursor proteins into their biologically active products. Furin is also utilized by several pathogens, where cleavage by Furin is needed for their functionality. This includes bacterial toxins, viral envelopes such as those of Human Immunodeficiency Virus (HIV), Ebola, and Marburg virus, as well as the spike protein of the SARS-Cov-2. Targeting host cell Furin is therefore a potential novel therapeutic option against these Furin-dependent infections. Of note, viruses develop high pathogenicity once they become reactive with Furin and other PC ([@bib41]).

A notable feature of SARS-CoV-2 is a polybasic cleavage site at the junction of S1 and S2, the two subunits of the spike. This allows effective cleavage by Furin, and has a role in determining viral infectivity and host range. These efficient polybasic cleavage sites have not been observed in related lineages of beta-coronaviruses. The acquisition of such polybasic cleavage site might have resulted from a point mutation, or from exchange of genetic material with another bat virus such as one of the filoviruses that share this common feature and a common intermediate host, namely bats ([@bib21]).

The subtilisin-like proteases, such as Furin, require polybasic cleavage sites rather than monobasic cleavage sites to activate respective viruses. A good example for this is, the difference in pathogenicity between highly pathogenic influenza strains, and those with lesser pathogenicity ([@bib9]).

2. Furin upregulation in relation to metabolic syndrome, aging and androgen levels {#sec2}
----------------------------------------------------------------------------------

Several demographic factors as well as disease states have been linked to increased COVID-19 complications, notably metabolic syndrome including diabetes and obesity ([@bib1]; [@bib8]; [@bib29]; [@bib37]). Aging and male gender have been also linked to augmented profile of COVID-19 complications. Could there be a relationship between Furin and COVID-19 severity in such risk factors ([@bib27]; [@bib37]; [@bib44]).

Although Furin is a membrane protein, earlier work indicates the existence of a secreted form of Furin. It has been previously shown that cells transfected with a recombinant Furin gene secrete a soluble truncated Furin protein, with similar enzymatic activity as the membrane-bound protein. Furthermore, it is established that Furin is partially shed from most cells.

### 2.1. Furin and diabetes {#sec2.1}

Plasma Furin levels were associated with future DM (Diabetes Mellitus) and obesity, independently of all traditional DM risk factors. Regarding potential mechanisms, as Furin is responsible for the maturation of the insulin pro-receptor; one could speculate that more Furin in the circulation reflects a compensatory mechanism to increase the synthesis of active insulin receptors ([@bib12]; [@bib20]). Another possible mechanism of action of Furin in DM development may be via pancreatic beta cells, as Furin has been demonstrated to control the proliferation and differentiation of pancreatic beta cell lines, as well as involvement in the maturation of insulin secretory granules ([@bib25]).

### 2.2. Furin and cholesterol {#sec2.2}

Furthermore, circulating Furin cleavage of PCSK9 (proprotein convertases subtilisin/kexin 9) implies a regulatory role on LDL (low-density lipoproteins) receptors and cholesterol levels. There appears to be a sort of cholesterol dependent priming of SARS-Cov-2 viral entry, where cellular loading with cholesterol using apolipoprotein E, showed enhancement of endocytic entry of SARS-Cov-2. Twice the normal entry points for SARS-Cov-2 were found in the setting of increased cholesterol. Cholesterol is further implicated in trafficking of ACE2 (Angiotensin Converting Enzyme 2), the known receptor and entry point of the SARS-Cov-2 virus; cholesterol increased receptor binding domains. A cholesterol dependent theory for COVID-19 mortality is suggested; as those with increased cholesterol, i.e. obese, diabetic, and elderly, are at increased risk owing to Furin priming, and increased viral entry points ([@bib45]).

### 2.3. Furin and obesity {#sec2.3}

Kappert et al. underlined the importance of intracellular Furin in the pathogenesis of obesity, and related cardiometabolic syndrome. Furin has been found to play a role in redirecting lipid deposition in white adipose tissue. Moreover, Furin was found in abundance in mononuclear cells leading to increased interaction and cell signaling between adipocytes and mononuclear inflammatory cells. The latter paracrine mechanism induces vascular remodeling, and atherosclerosis through lipid deposition and chronic inflammation ([@bib24]).

The increased cellular and serum levels of Furin in diabetes, hypercholesterolemia, and obesity might explain the increased profile of COVID-19 complication in such disease states.

### 2.4. Furin and androgen {#sec2.4}

The only proven relationship between PCs including furin and androgen, has been proven in the context of androgen dependent prostatic cancer. Couture et al. found that proprotein convertase activity is upregulated in prostate cancer. This might be mediated through increased androgen levels, or through increased activity of androgen receptors that act as protein chaperones to several types of proprotein convertases. This linear relationship between PCs and androgen might explain why COVID-19 disease burden is higher in males compared to females ([@bib10]; [@bib43]).

### 2.5. Furin and aging {#sec2.5}

There is little data about Furin upregulation in aging. To our knowledge the only study to date to outline this relationship was conducted by Grobelna and colleagues. Grobelna et al. proved that Furin is implicated in vascular aging; and proved as well that the serum levels of Furin are positively correlated with age dependent atherosclerosis ([@bib17]).

The above relationship might explain the increased deaths from COVID-19 in the elderly.

In view of the above, serum Furin levels might serve as an independent predictor of COVID-19 complications in at risk groups.

### 2.6. Furin levels in smokers {#sec2.6}

Interestingly, Ranta and colleagues found an interesting relationship between smoking and shed serum Furin levels. Their study explored whether serum Furin levels can be used as a biomarker for septicemia, and results showed that serum Furin levels were reduced in smokers compared to non-smokers ([@bib38]). The latter finding might explain why smokers had lesser COVID-19 complications ([@bib22]).

3. Furin and endothelial pathogenicity and tropism {#sec3}
--------------------------------------------------

Furin is highly expressed in vascular endothelial cells. Mayer and colleagues succeeded in revealing the exact endothelial location of Furin. They demonstrated by electron microscopy that Furin is located over the plasma membrane of endothelial cells of the continuous, fenestrated, and discontinuous capillaries. This location goes in agreement with several previous studies relating Furin to the endothelial permeability of many molecules, as well as some organisms ([@bib28]).

Moreover, Furin-processed proteins, such as cadherins, vascular endothelial growth factor, factor IX, and von Willebrand factor, are known to be involved in vascular permeability. These facts constitute strong evidence that Furin plays a major role in viral tropism to the endothelium. As discussed earlier, several viruses harbor a polybasic cleavage site that allows easier and canonical binding to Furin, allowing them to exploit Furin to regulate cell entry and infectivity ([@bib40]). These include; Flaviviruses including Dengue fever virus, HIV, highly pathogenic strains of influenza viruses, and SARS-CoV-2 ([@bib9]). The aforementioned viruses have a selective tropism to the endothelium. Their pathogenesis relies either on transfection of endothelial cells, or impairment of endothelial function through indirect inflammatory mechanisms without endothelial penetration. It is unclear if the observed endothelial pathogenicity is the result of Furin mediated canonical damage, or due to other incompletely understood mechanisms ([@bib36]) ([Table 1](#tbl1){ref-type="table"} summarizes the mechanisms of each of the mentioned viruses in inducing endothelial damage and the resultant clinical manifestations).Table 1Summary of endothelial pathogenicity of viruses activated canonically by Furin.Table 1VirusEndothelium TropismClinical evidence of endothelial dysfunctionSARS-CoV-2Direct: Transfection of endothelial cells by ACE2 receptors that are highly expressed in endothelial cells\
Indirect-Inactivation of eNOS leading to depletion of Nitric Oxide and impaired vascular relaxibility-Upregulation of highly proinflammatory cytokines such as IL-6 and suppression of regulatory cytokines such as IL-7 leading to endothelial inflammation-Endotheliitis with diffuse endothelial inflammation.-Micro- & macrovascular thrombosis both in the venous and arterial circulations.HIVDirect:-Active secretion of HIV proteins, namely gp120 and Tat into the endothelial cell micro-environmentIndirect:-Active transfer of Nef onto endothelial cells. These events result in enhanced adhesiveness, permeability, cell proliferation, apoptosis, oxidative stress as well as activation of cytokine secretionAccelerated atherosclerosis starting by increased intima-media thickness.\
Subsequent increase in coronary artery disease, peripheral vascular diseaseInfluenzaDirect:\
Apoptosis of infected endothelial cells and significant drop in TEER indicated increased permeability to ions and macromolecules.\
Indirect:\
-Influenza induced degradation of tight junction protein claudin-5 by matrix metalloproteinase\
-Increases macrophage entry into arterial wallAcute Lung injury owing to pulmonary microvascular leakage and apoptosis\
Exacerbation of existing cardiovascular disease with increased risk for CV mortality\
Risk of myocardial infarction, pericarditis and effusions, heart failure, myocarditis, and cardiac conduction system affection\
Deceased mortality and incidence of any cardiovascular event in vaccinated persons\
Increased pro-inflammatory and pro-thrombotic cytokines, increased plasma viscosity, hemo-concentration, hypoxia, and demand ischemia\
Increase platelet aggregation, clotting time, DIC, FDP, soluble fibrin, tissue factorHemorrhagic FeversFilovirus:\
Marburg virusDirect\
Viral replication in endothelial cells associated with virus induced-cytokine release lead to endothelial damage\
Indirect:\
MBG virus\'s primary target cells are monocytes and macrophage. MBG infects mono\\macrophages leading to their activation resulting in release of several cytokines, one of which is TNF alpha. TNF alpha leads to an increase in Para endothelial permeability by formation of inter-endothelial gaps. This vascular instability results in fulminant shock and defective hemostasis-Endothelial damage upregulates the coagulation cascade by releasing Tissue factor leading to fibrin clots depositionVenous thromboembolism\
DIC\
Hemorrhage (mucosal/sub mucosal/internal) and third space loss leading to hypovolemic and distributive shock\
CNS: Migraines, StrokesDengue Fever VirusesDirect:\
Direct Transfection of endothelial cells has been rarely demonstrated from autopsies\
Indirect:-Activation of endothelial secretion of prothrombotic factors leading to widespread thrombosisA main mechanism of Dengue virus is diapedesis of circulating mononuclear and red blood cells across the vascular endothelium, perivascular cellular accumulation and edema[^1]

An important theory that can explain the endothelial pathogenicity of those viruses is the "vascular zip code" theory. Endothelial penetrability of drugs and other molecules have been the focus of many onco-pharmacology studies. The high vascularity of tumors makes targeting the endothelium an important selective strategy for treatment. Such studies have revealed that coupling drugs or nanoparticles with basic amino-acid residues such as lysine or arginine, renders those compounds highly tropic to the endothelium. SARS-CoV-2, filoviruses, HIV, and highly pathogenic strains of influenza, harbor a polybasic amino-acid sequence that not only make them readily activated by Furin, but might explain their ability to transfect the endothelial cells ([@bib11]; [@bib15]; [@bib19]; [@bib39]).

4. Furin inhibition; exploiting an old strategy against COVID-19 {#sec4}
----------------------------------------------------------------

### 4.1. Naturally occurring substances acting as selective furin inhibitors {#sec4.1}

Furin inhibition has been tried against viruses with polybasic Furin cleavage sites with debatable results. Luteolin, a molecule derived from traditional Chinese herbal products, has been found to decrease Dengue Fever severity and viral load through selective inhibition of Furin ([@bib33]).

Further evidence to the role of Furin inhibitors as a potential therapeutic target, is in their use in the treatment of HIV. Hallenberger et al. confirmed the role of an old generation of Furin inhibitors, *peptidyl-chloromethyl ketones*, in interruption of formation of infectious viral particles. A major setback is the high toxicity of these compounds ([@bib18]).

Gagnon et al. concluded that the use of a nanomolar particle stabilized by *Aza-Beta-amino-acid* could effectively inhibit H5N1 influenza ([@bib13]).

As mentioned previously, COVID-19 related deaths and complications are paradoxically reduced in smokers, smoking might operate through reducing endothelial penetration of COVID-19 by inhibition of Furin ([@bib38]). Israel et al. proved in his large observational study that COVID-19 complications were lesser insmokers ([@bib22]); a finding that was also confirmed by Gonzalez-Rubio and colleagues, who concluded that cytokine release is tamed by Nicotine ([@bib16]). The latter findings could lead to the therapeutic use of Nicotine patches after confirming this role through clinical trials.

### 4.2. The FDA (Food and drug administration) approved colchicine {#sec4.2}

Colchicine is a drug that is used in the management of inflammatory complications of Gout, as well as auto-inflammatory syndromes such as familial Mediterranean fever. Colchicine acts by targeting several inflammatory pathways, and has been found to target specifically endothelial inflammation and vascular degeneration through Furin. ([@bib46]). Montealegre-Gómez confirmed colchicine drug potential in the setting ofCOVID-19, in a small cohort of patients in Bogota, Colombia. This role should be consolidated by larger scale clinical trials ([@bib31]).

### 4.3. Ion-channel inhibitors {#sec4.3}

Furin is a cellular protein. There is clear evidence that Furin interacts with intracellular ions. Magnesium, the second most occurring intracellular ion after Potassium, has been shown to activate Furin ([@bib23]).

Molloy and colleagues demonstrated that Furin is a calcium dependent enzyme. The levels of intracellular calcium are critical for the activation of Furin ([@bib30]). Another evidence of the relationship between Furin activity and calcium has been elucidated by Yamada et al. Yamada et al. underlined the role of Furin inhibitors in prevention of excessive neuronal damage resulting from calcium influx following hypoxic insult ([@bib47]). In this aspect, blocking calcium channels can be an effective strategy for Furin-activated organisms. Li et al. proved, in 2019, that Calcium Channel Blocker (CCB) can decrease the severity of severe fever and thrombocytopenia syndrome; a tick-borne hemorrhagic fever. Zhang et al. underlined the beneficial role of CCB in patients with COVID-19 ([@bib26]).

There is no clear relationship between intracellular potassium levels and Furin activity; however amiodarone had been shown to block viral entry of some flaviruses. This role has been confirmed against COVID-19 by [@bib14].

This antiviral role of ion channel blockers is speculated to be more effective with low viral loads, and at the start of infection, when virus entry into target cells is the dominant step ([Fig. 1](#fig1){ref-type="fig"} ).Fig. 1Summarizes the Furin mediated endothelial tropism of SARS-CoV-2 and the ensuing therapeutic targets.Fig. 1

5. Conclusion {#sec5}
-------------

The acquisition of polybasic cleavage site by the new SARS-CoV-2 seems to be an important feature for endothelial penetrability and pathogenicity of COVID-19. This might occur through its canonical activation by Furin, and through endothelial affinity to basic amino acid residues. Additionally, the interaction of SARS-CoV-2 with Furin offers an explanation to the augmented manifestations of COVID-19 in obese and diabetic patients, as well as in males and elderly people.

Screening serum levels of Furin early in the course of COVID-19 complications might serve as an important strategy to anticipate COVID-19 poor outcomes, and preventing them.

Finally, and importantly, this relationship opens up new therapeutic strategies in the treatment of COVID-19, such as the use of Chinese herbals, ion channel inhibitors, nicotine patches, and Colchicine, for prevention of endothelial involvement and multi-organ failure in affected patients.

6. Recommendations {#sec6}
------------------

In view of the above, we strongly recommend the screening of baseline serum Furin levels early in the course of COVID-19 infections, and correlating such levels with COVID-19 complications and mortality; we recommend the launching of clinical trials involving the use of the aforementioned Furin inhibitors in COVID-19 patients.
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[^1]: Abbreviations: ACE2: Angiotensin-converting enzyme 2, CNS: Central nervous system, CV: Cardiovascular, DIC: Disseminated intravascular coagulopathy, eNOS: Endothelial Nitric Oxide Synthase, FDP: Fibrin degradation products, gp120: Envelope glycoprotein 120, HIV: Human immunodeficiency virus, IL: Interleukin, MBG: Marburg virus, Nef: Negative regulatory factor, Tat: transactivator of transcription, TEER: Trans epithelial/Trans endothelial Electrical Resistance, TNF: Tumor necrosis factor.
